ROMANO, ELOISA
 Distribuzione geografica
Continente #
NA - Nord America 5.365
EU - Europa 3.333
AS - Asia 3.238
SA - Sud America 507
AF - Africa 91
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.584
Nazione #
US - Stati Uniti d'America 5.270
RU - Federazione Russa 1.280
SG - Singapore 912
CN - Cina 857
PL - Polonia 520
HK - Hong Kong 433
BR - Brasile 405
IT - Italia 380
VN - Vietnam 316
KR - Corea 275
IE - Irlanda 252
SE - Svezia 244
FI - Finlandia 159
IN - India 136
FR - Francia 132
DE - Germania 125
GB - Regno Unito 76
CA - Canada 65
NL - Olanda 54
ID - Indonesia 53
JO - Giordania 52
AU - Australia 45
JP - Giappone 43
BD - Bangladesh 42
AR - Argentina 37
ES - Italia 25
IQ - Iraq 23
ZA - Sudafrica 22
MX - Messico 20
EC - Ecuador 19
CH - Svizzera 16
TR - Turchia 16
UA - Ucraina 16
PH - Filippine 15
BE - Belgio 14
MA - Marocco 12
CI - Costa d'Avorio 10
CO - Colombia 10
NG - Nigeria 10
PK - Pakistan 10
UY - Uruguay 9
UZ - Uzbekistan 9
VE - Venezuela 9
AZ - Azerbaigian 8
TN - Tunisia 7
BJ - Benin 6
CL - Cile 6
LU - Lussemburgo 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
BG - Bulgaria 5
DK - Danimarca 5
EG - Egitto 5
KE - Kenya 5
KZ - Kazakistan 5
NP - Nepal 5
PE - Perù 5
SA - Arabia Saudita 5
SN - Senegal 5
JM - Giamaica 4
LT - Lituania 4
RO - Romania 4
TH - Thailandia 4
CG - Congo 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
KG - Kirghizistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 12.581
Città #
Santa Clara 1.099
Ashburn 765
Singapore 721
Warsaw 517
Fairfield 433
Hong Kong 377
Seoul 273
Dublin 247
Chandler 244
Hefei 238
Woodbridge 208
San Jose 179
Seattle 178
Houston 166
Cambridge 156
Beijing 155
Wilmington 128
Florence 122
Ho Chi Minh City 108
Los Angeles 83
Helsinki 81
Ann Arbor 79
Dallas 76
Munich 72
Council Bluffs 71
Lawrence 71
Altamura 69
Lauterbourg 69
Hanoi 65
New York 62
Mumbai 60
Princeton 57
Moscow 53
Buffalo 48
Boston 45
The Dalles 44
Melbourne 39
São Paulo 39
Paris 38
Tokyo 37
Jakarta 36
Montreal 36
Shanghai 36
Kent 34
Turku 32
Zeist 32
San Diego 26
Chicago 24
Redondo Beach 23
Boardman 22
Clifton 20
Lappeenranta 20
Milan 20
Orem 20
Medford 19
Fiesole 17
Pune 17
Chennai 15
Guangzhou 15
Rio de Janeiro 15
Tianjin 15
Toronto 15
Baghdad 14
Dong Ket 14
Phoenix 14
Atlanta 13
Falls Church 13
Johannesburg 13
Manchester 13
Bengaluru 12
Jacksonville 12
London 12
Da Nang 11
Denver 11
Hillsboro 11
Abidjan 10
Abuja 10
Frankfurt am Main 10
Haiphong 10
West Jordan 10
Biên Hòa 8
Brasília 8
Brooklyn 8
Brussels 8
Hải Dương 8
Mexico City 8
Porto Alegre 8
Rome 8
Shenzhen 8
Tashkent 8
Baku 7
Castelliri 7
Poplar 7
San Francisco 7
Sesto Fiorentino 7
Stockholm 7
Yubileyny 7
Amman 6
Andover 6
Barnet 6
Totale 8.441
Nome #
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 333
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 320
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 301
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 258
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 255
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 242
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 224
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 213
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 206
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 204
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 198
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 198
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 197
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 195
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 191
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 187
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 182
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 182
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 182
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 181
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 177
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 177
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 173
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 173
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 171
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 170
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 170
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 169
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 168
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 166
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis 162
Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis 160
Skin telocyte secretome as conditioned medium prevents profibrotic differentiation of skin fibroblasts into myofibroblasts 158
Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis 158
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 157
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 157
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 156
The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes 155
Immunohistochemical and ultrastructural identification of telocytes in the lamina propria of human vaginal mucosa 154
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 154
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 154
STIMULATION OF SOLUBLE GUANYLATE CYCLASE (sGC) FOSTERS ANGIOGENESIS AND BLUNTS ENDOTHELIAL-TO-MESENCHYMAL TRANSITION (EndoMT) OF SYSTEMIC SCLEROSIS (SSc) DERMAL MICROVASCULAR ENDOTHELIAL CELLS 154
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts 152
Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis 152
Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review 152
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 148
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 148
The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis 147
Oral lactobacillus species in systemic sclerosis 146
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of scleroderma endothelial cells 145
Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment 144
Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets 144
FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists 140
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 140
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells 139
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 138
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 133
Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis 132
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis. 132
A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems 132
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 131
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 129
Recent Insights into Cellular and Molecular Mechanisms of Defective Angiogenesis in Systemic Sclerosis 128
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 128
The contribution of endothelial cells to tissue fibrosis 127
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 121
Blockade of sialylation with decrease in polysialic acid levels counteracts transforming growth factor β1-induced skin fibroblast-to-myofibroblast transition 120
Impairment in the telocyte/CD34+ stromal cell network in human rheumatoid arthritis synovium 120
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting 120
The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview 118
Skin Telocyte Secretome as Conditioned Medium Prevents Profibrotic Differentiation of Skin Fibroblasts into Myofibroblasts 106
Stiff Skin Syndrome 104
New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy 99
Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement 99
The authors' reply 95
Soluble α-Klotho protects dermal microvascular endothelial cells against endothelial-to-mesenchymal transition 91
Pathophysiologic implications and therapeutic potentials of telocytes in multiorgan fibrosis 89
The genetics of systemic sclerosis: an update. 80
Stimulation of soluble guanylate cyclase: A novel approach to treat conjunctival fibrosis 77
Soluble α-Klotho protects dermal microvascular endothelial cells against endothelial-to-myofibroblast transition 72
Telocytes in skeletal muscle: Emerging players in homeostasis and repair/regeneration 21
The Missing Link in Joint Homeostasis: Telocytes as Master Regulators of the Synovial Lymphatic System 15
Totale 12.796
Categoria #
all - tutte 34.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 39 47
2021/2022361 14 10 19 12 23 33 7 12 34 23 51 123
2022/20231.132 104 235 43 79 56 196 163 49 125 11 37 34
2023/2024587 14 60 85 31 46 81 36 112 10 29 40 43
2024/20253.651 119 387 271 577 1.023 340 133 250 114 96 154 187
2025/20264.786 488 606 575 665 592 203 544 267 363 308 175 0
Totale 12.796